DFW Capital Partners
Edit

DFW Capital Partners

https://dfwcapital.com
Last activity: 16.09.2026
Active
Invests in categories: AssistedBusinessCenterEnergyTechIndustryManagementMedtechProviderServiceTechnology
DFW Capital Partners Growth-driven investors building leading service companies for over 30 years ABOUT US Since 1983, DFW has been investing in and acquiring high-growth businesses in Healthcare Services, Business Services, and Industrial Services. Our Approach For over 30 years, DFW Management ...
News
145
Portfolio
27
Persons
18
Mentions
16
Employees: 11-50

Portfolio 27

DateNameWebsiteTotal RaisedLocation
03.08.2025singlepointhc.com--
25.09.2024Bart &...bna-inc.com-United Sta...
09.02.2024Harris CPA...harriscpas.com-United Sta...
09.02.2024sorren.com--
04.11.2023Voiantvoiantclinical.com-United Sta...
01.06.2023Hippo Vete...hippovets.com-United Sta...
19.05.2023keptcompanies.com-United Sta...
19.05.2023North Amer...northamericanrailsolutions.com-United Sta...
23.12.2021acumetisglobal.com--
23.12.2021Herspiegel...herspiegelconsulting.com-United Sta...
Show more

Persons 18

DateFirst NameLast NameTitleLinkedInLocation
-RhodaMinderhoudFund Contr...-
-CarynSiminoffDirector o...-
-RobertMcDonnell--
-MaxFranklinAssociate-
-AndrewP. WhitePartner-
-AngelaWuAssociate-
-RyanWhite--
-KatieLeshinskyDirector o...-
-HunterOstadVice Presi...-
-PatrickLinSenior Ass...-
Show more

News 145

DateTitleDescription
05.08.2026Voiant Expands Clinical Trial Imaging Services into Obesity and Metabolic Disease ResearchVoiant, the industry’s leading clinical trial imaging solution provider, today announced the launch of its clinical trial imaging services into obesity and metabolic disease research. The strategic therapeutic area expansion builds upon Voi...
16.07.2026DFW Capital Partners Announces Leadership Additions and Promotions to Support Continued GrowthDFW Capital Partners Announces Leadership Additions and Promotions to Support Continued Growth Jake Schuckman Joins as Vice President; Hunter Ostad Promoted to Vice President Following Strong Investment Activity in 2026 New York, NY — DFW C...
08.07.2026Saol Therapeutics Resubmits the New Drug Application for SL1009 (DCA) for the Treatment of Pyruvate Dehydrogenase Complex Deficiency (PDCD), an Ultra-Rare DiseaseROSWELL, Ga. and DUBLIN and HAMILTON, Bermuda, July 7, 2026 /PRNewswire/ — Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, today announced the resubmission of its New Drug Application (NDA) to the U.S. Food and D...
25.06.2026DFW Named one of PrivateEquityCXO and Falcon Partners 2026, “Top 50 Private Equity Firms for Executives” for the Fourth Consecutive YearCLEVELAND, OH. – June 23, 2026 PrivateEquityCXO and Falcon Partners have released the 2026 Top 50 Private Equity Firms for Executives Report, recognizing the firms whose governance approach, partnership style and engagement with leadership ...
16.06.2026Singlepoint Healthcare Acquires Healix, Expanding National Infusion CapabilitiesCHICAGO, June 16, 2026 — Singlepoint Healthcare (Singlepoint), today announced its acquisition of Healix, a national infusion services provider supporting physician-owned and ambulatory infusion centers across the United States. The acquisi...
15.05.2026North American Rail Solutions acquires Queen City via US Subsidiary; American TrackFORT WORTH, Texas, May 13, 2026 /PRNewswire/ — North American Rail Solutions (“NARS”), through its subsidiary American Track, is proud to announce that it has acquired Queen City Railroad Construction (“QCRC”). Based in Knoxville, TN, QCRC ...
29.04.2026DFW Completes Sale of AQUALIS to Fusion Capital PartnersMORRISVILLE, N.C. – AQUALIS announced today that Fusion Capital Partners (“Fusion”) has completed a growth investment in AQUALIS, the leading provider of sustainable water compliance and management services nationwide. Building on the stron...
15.04.2026Acumetis Launches as a Single Integrated Brand to Transform Life Sciences CommercializationAcumetis Launches as a Single Integrated Brand to Transform Life Sciences Commercialization Leading Pharmaceutical and Biotech Consultancies Combine to Create a Full-Service Commercialization Powerhouse Acumetis – a new global commercializa...
25.02.2026DFW Completes Sale of Sev1Tech to ERT, a Macquarie Capital-backed companyDFW Completes Sale of Sev1Tech to ERT, a Macquarie Capital-backed company DFW Capital Partners (“DFW”) is pleased to announce that it has completed the sale of its portfolio company, Sev1Tech (“Sev1Tech”, or the “Company”) to ERT, a Macquar...
25.02.2026Organon Enters into Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine DeviceMIUDELLA® is a strategic addition to Organon’s portfolio, strengthening its long‑term commitment to advancing women’s health JERSEY CITY, N.J., February 23, 2026 — Organon (NYSE: OGN), a global healthcare company with a mission to deliver i...
Show more

Mentions in press and media 16

DateTitleDescription
03.01.2023DFW Closes Latest Investment Fund at $800 Million Hard CapFor Immediate Release January 3, 2023 Teaneck, NJ
10.02.2022Runway Growth Capital Announces a Senior Secured Term Loan of $30 Million to EPIC IO TechnologiesWOODSIDE, California, February 10, 2022 – Runway Growth Capital LLC (“Runway”), a leading provider of growth loans to both venture and non-venture backed companies seeking an alternative to raising equity, today announced the close of a sen...
09.10.2019DFW Capital Partners Completes Growth Investment in Regulatory and Quality SolutionsDFW Capital Partners, in partnership with Chartwell Investments Entrepreneur & Founder Capital, announced today that it has completed a growth investment in Regulatory and Quality Solutions, a leading provider of regulatory and quality ...
04.04.2019What Happens When ‘Fake It Till You Make It’ Goes Too Far: Term Sheet for April 4, 2019SECOND ACT If you read the book Bad Blood or watched the HBO documentary The Inventor, both of which detail the implosion of blood testing company Theranos, you might think that there’s no way ex-CEO Elizabeth Holmes makes a comeback. Paid ...
03.04.2019DFW Capital Partners Closes Sixth Fund, at $500MDFW Capital Partners, a Teaneck, New Jersey-based private equity firm, closed its sixth fund, at $500m. DFW Capital Partners VI, L.P., is an investment partnership dedicated to making control investments in lowermiddle market service compan...
03.04.2019DFW Closes Fund VI at $500 Million Hard CapDFW Capital Partners announced today that it has held a first and final closing of DFW Capital Partners VI, L.P., an investment partnership dedicated to making control investments in lower- middle market service companies. Capitalized with ...
17.04.2018DFW Capital Partners Invests in ReSource ProDFW Capital Partners, a 35-year-old private equity firm based in New Jersey, has completed an investment in ReSource Pro, becoming the company's majority owner. ReSource Pro, a leader in operations efficiency and business process solutions ...
26.03.2018DFW Invests in INSIGHT2PROFITDFW Capital Partners announced today that it has closed a strategic investment in INSIGHT2PROFIT. DFW is a private equity investment firm with over $600 million of assets under management focused on the lower middle market. “We are excited ...
26.03.2018DFW Invests in INSIGHT2PROFITDFW Capital Partners announced today that it has closed a strategic investment in INSIGHT2PROFIT. DFW is a private equity investment firm with over $600 million of assets under management focused on the lower middle market. “We are excited ...
04.04.2016DFW Closes Fund V at $360 Million, Exceeding TargetDFW Capital Partners (“DFW”) announced today that it has held a first and final closing of DFW Capital Partners V, L.P. (“Fund V”), an investment partnership dedicated to making control investments in lower-middle market service companies. ...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In